Paper40237828
[Diagnosis and drug therapy of chronic rhinosinusitis].
Becker S. HNO, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Diagnosis and drug therapy of chronic rhinosinusitis]. Papers, record 40237828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40237828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Rhinitis | Major topic |
| Sinusitis | Major topic |
| Humans | |
| Chronic Disease | |
| Evidence-Based Medicine | |
| Rhinosinusitis | |
| Treatment Outcome |
Source PubMed
References194
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37203259 | Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL). | Allergy | 2023 | https://conductscience.org/library/papers/37203259 | PubMed |
| 2 | 35386961 | Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA. | Front Allergy | 2021 | https://conductscience.org/library/papers/35386961 | PubMed |
| 3 | 36050129 | Endotypes of atopic dermatitis and food allergy. | J Allergy Clin Immunol | 2023 | https://conductscience.org/library/papers/36050129 | PubMed |
| 4 | 39149992 | Comparative Effectiveness of Dupilumab Versus Sinus Surgery for Chronic Rhinosinusitis With Polyps: Systematic Review and a Meta-Analysis. | Am J Rhinol Allergy | 2024 | https://conductscience.org/library/papers/39149992 | PubMed |
| 5 | 28651294 | [IgE and Anti-IgE in Asthma: A Chequered History]. | Pneumologie | 2017 | https://conductscience.org/library/papers/28651294 | PubMed |
| 6 | 9013989 | Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. | J Immunol | 1997 | https://conductscience.org/library/papers/9013989 | PubMed |
| 7 | 33271403 | Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22). | J Psychosom Res | 2021 | https://conductscience.org/library/papers/33271403 | PubMed |
| 8 | 21605125 | Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. | Allergy | 2011 | https://conductscience.org/library/papers/21605125 | PubMed |
| 9 | 36832203 | The Diagnostic and Prognostic Role of Biomarkers in Chronic Rhinosinusitis. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36832203 | PubMed |
| 10 | 39641626 | Algorithm for the Management of Primary Diffuse Chronic Rhinosinusitis. | Allergy | 2025 | https://conductscience.org/library/papers/39641626 | PubMed |
| 11 | 32498540 | Histopathologic Influences of Comorbid Smoking Status in Chronic Rhinosinusitis. | Am J Rhinol Allergy | 2020 | https://conductscience.org/library/papers/32498540 | PubMed |
| 12 | 16405274 | Decongestant effects of nasal xylometazoline and mometasone furoate in persistent allergic rhinitis. | Rhinology | 2005 | https://conductscience.org/library/papers/16405274 | PubMed |
| 13 | 33846604 | Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33846604 | PubMed |
| 14 | 38892164 | Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892164 | PubMed |
| 15 | 32294933 | Nasal Epithelial Cells Activated with Alternaria and House Dust Mite Induce Not Only Th2 but Also Th1 Immune Responses. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32294933 | PubMed |
| 16 | 34592767 | Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC). | Laryngorhinootologie | 2021 | https://conductscience.org/library/papers/34592767 | PubMed |
| 17 | 31908763 | Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. | Clin Transl Allergy | 2020 | https://conductscience.org/library/papers/31908763 | PubMed |
| 18 | 22287332 | Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic review. | Int Forum Allergy Rhinol | 2011 | https://conductscience.org/library/papers/22287332 | PubMed |
| 19 | 31220711 | Mucosal IgE immune responses in respiratory diseases. | Curr Opin Pharmacol | 2019 | https://conductscience.org/library/papers/31220711 | PubMed |
| 20 | 27113482 | Systemic and topical antibiotics for chronic rhinosinusitis. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27113482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40237828
GET https://conductscience.org/api/papers/v1/40237828/references?page=2